939 completed. 939 Phase 3, 77 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 939 | Completed 939 |
| Phase 2 | 77 | Completed 77 |
Follow Arthritis: new trials by email Literature Review of Arthritis trials Research Report on Arthritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Counterpain PXM Versus Diclofenac Versus Piroxicam Piroxicam plus Counterirritant (brand name Counterpain® PXM)., Diclofenac Sodium 10 mg (Brand Name Hotin® DCL), Piroxicam 0.5% (Brand name Pirofel® gel) - Ankle Sprain, Back Pain | Phase 3 | Completed | Taisho Pharmaceutical Indonesia | 180 | 2025-11-04 | 2026-03-16 |
| A Randomized Clinical Trial Evaluating the Efficacy of Clinical Pharmacist Assistance Along With Pharmaceutical and Non-pharmaceutical Therapy in the Early Rheumatoid Arthritis Clinical Pharmacist Led Intervention, DMARD Therapy - Early Rheumatoid Arthritis | Phase 2 / Phase 3 | Completed | Deraya University | 70 | 2025-04-10 | 2026-07-24 |
| Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301) AR882 50 mg, AR882 75 mg, Placebo - Gout, Arthritis, Gouty | Phase 3 | Completed | Arthrosi Therapeutics | 866 | 2025-03-11 | 2026-09-28 |
| A Study to Evaluate Efficacy and Safety of AMZ001 for the Treatment of Knee Osteoarthritis Symptoms AMZ001 Diclofenac gel, Placebo gel - Osteoarthritis of Knee, Osteoarthritis, Knee | Phase 3 | Completed | Amzell | 549 | 2025-02-18 | 2026-07-15 |
| Probiotic Supplements in Osteoarthritis Probiotic Formula, Control - Osteoarthritis, Knee | Phase 3 | Completed | Beni-Suef University | 146 | 2025-02-15 | 2026-07-24 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Study Participants With Active Psoriatic Arthritis Bimekizumab, Risankizumab, Placebo - Psoriatic Arthritis | Phase 3 | Completed | UCB Biopharma SRL | 553 | 2024-10-21 | 2026-09-02 |
| A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [Proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis MB04 (proposed biosimilar to etanercept), Enbrel (etanercept) - Rheumatoid Arthritis (RA) | Phase 3 | Completed | mAbxience Research S.L. | 501 | 2024-10-03 | 2026-10-08 |
| Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or Overweight Ixekizumab, Tirzepatide - Psoriatic Arthritis, Obesity | Phase 3 | Completed | Eli Lilly and Company | 279 | 2024-09-24 | 2026-05-13 |
| Efficacy and Safety of Celecoxib/Acetaminophen Versus Celecoxib for Diagnosed Osteoarthritis in Acute Exacerbation Celecoxib + Acetaminophen, Celecoxib - Joint Pain, Knee Osteoarthritis | Phase 3 | Completed | Laboratorios Silanes S.A. de C.V. | 231 | 2024-09-09 | 2026-10-23 |
| Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty Multiprofen-CC™ plus standard treatment, Placebo plus standard treatment - Postsurgical Pain | Phase 3 | Completed | KAZM Pharmaceuticals Inc. | 306 | 2024-09-09 | 2026-06-29 |
| Evaluating the Efficacy and Safety of Intra-articular Injection of HS-20116 in Patients With Knee Osteoarthritis HS-20116, Medical Chitosan (for intra-articular injection) - Knee Osteoarthritis | Phase 3 | Completed | Jiangsu Hansoh Pharmaceutical Co., Ltd. | 192 | 2024-08-13 | 2025-07-09 |
| Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) AR882 50 mg, AR882 75 mg, Placebo - Gout, Arthritis, Gouty | Phase 3 | Completed | Arthrosi Therapeutics | 818 | 2024-06-26 | 2026-10-14 |
| Efficacy and Safety of Etoricoxib+Diacerein in Osteoarthritis. Etoricoxib 90 mg + diacerein 50 mg, Meloxicam 15 mg + diacerein 50 mg - Pain Management, Osteoarthritis | Phase 3 | Completed | Laboratorios Liomont | 123 | 2024-05-24 | 2026-04-29 |
| § Procaine Periarticular Injections for Pain Reduction in Elderly With Osteoarthritis Periarticular Procaine Injection (PAPI), Kinesiotherapy - HIP AND KNEE OSTEOARTHRITIS, Geriatric Assessment | Phase 3 | Completed | Sf Luca Chronic Disease Hospital | 203 | 2024-02-08 | 2024-12-05 |
| Comparing Efficacy of Autologous Serum Eye Drops With and Without Insulin in Autoimmune Dry Eye. recombinant human insulin, Autologous serum - Dry Eye, Sjogren Syndrome | Phase 3 | Completed | Instituto de Oftalmología Fundación Conde de Valenciana | 25 | 2024-02-01 | 2026-08-27 |
| Paroxetine Safety and Efficacy in Rheumatoid Arthritis Methotrexate, Paroxetine - Rheumatoid Arthritis | Phase 3 | Completed | Mostafa Bahaa | 100 | 2024-01-31 | 2026-05-04 |
| A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity Dazodalibep, Placebo - Sjogren's Syndrome | Phase 3 | Completed | Amgen | 651 | 2024-01-24 | 2026-10-29 |
| An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease GNR-086, Ilaris® - Still's Disease Adult Onset | Phase 3 | Completed | AO GENERIUM | 118 | 2023-12-12 | 2025-08-17 |
| A Phase III Study to Evaluate the Efficacy and Safety of AK111 in Subjects With Active Ankylosing Spondylitis AK111, Placebo+AK111 - Ankylosing Spondylitis | Phase 3 | Completed | Akeso | 510 | 2023-11-22 | 2026-10-16 |
| A Phase 3 Study Comparing TLL-018 to Tofacitinib in RA Subjects With Inadequate Response or Intolerance to bDMARDs TLL-018, Tofacitinib - Rheumatoid Arthritis | Phase 3 | Completed | Hangzhou Highlightll Pharmaceutical Co., Ltd | 459 | 2023-11-15 | 2026-09-25 |
Showing 20 of 939. Sign in to see all of them.
Arthritis, Rheumatoid (361) · Osteoarthritis (219) · Osteoarthritis, Knee (167) · Arthritis, Psoriatic (74) · Spondylitis, Ankylosing (65) · Pain (50) · Arthritis, Juvenile (49) · Gout (37) · Osteoarthritis, Hip (33) · Joint Diseases (26) · Psoriasis (21) · Axial Spondyloarthritis (20) · Musculoskeletal Diseases (19) · Chronic Pain (18)
Musculoskeletal Diseases (920) · Joint Diseases (913) · Rheumatic Diseases (761) · Skin and Connective Tissue Diseases (507) · Connective Tissue Diseases (430) · Immune System Diseases (424) · Autoimmune Diseases (416) · Bone Diseases (154) · Spinal Diseases (148) · Spondylitis (147) · Spondylarthropathies (139) · Spondylarthritis (137) · Pathological Conditions, Signs and Symptoms (120) · Osteoarthritis (114)
Methotrexate (95) · tocilizumab (81) · Adalimumab (64) · Etanercept (33) · Certolizumab Pegol (32) · secukinumab (32) · Abatacept (30) · Celecoxib (29) · Infliximab (29) · Rituximab (27) · golimumab (22) · tofacitinib (22) · Naproxen (19) · Sodium Chloride (18) · Etoricoxib (14)
Hoffmann-La Roche (72) · Novartis Pharmaceuticals (43) · Pfizer (42) · Amgen (30) · Abbott (28) · Bristol-Myers Squibb (23) · Eli Lilly and Company (22) · Janssen Research & Development, LLC (17) · Centocor, Inc. (16) · Novartis (16) · UCB Pharma (13) · AbbVie (12) · Organon and Co (11) · Chugai Pharmaceutical (10) · UCB Biopharma SRL (10)
United States (393) · Germany (219) · Canada (190) · Poland (189) · Spain (171) · United Kingdom (162) · Russia (156) · France (147) · Czechia (138) · Hungary (131) · Australia (128) · Italy (125) · Mexico (124) · Belgium (121) · South Korea (108)
Takahiro Kakehi (8)
PMID 27338778, PMID 36526796, PMID 36931693, PMID 29244149, PMID 30649524, PMID 32816215, PMID 34870800, PMID 33263165, PMID 36600185, PMID 36601090, PMID 28143815, PMID 33127856, PMID 36814062, PMID 37453736, PMID 37982966, PMID 40875187, PMID 25047021, PMID 31203228, PMID 34921355, PMID 36754548, PMID 37945286, PMID 38446397, PMID 30177460, PMID 34706874, PMID 35577477, PMID 37316690, PMID 37460782, PMID 38958913, PMID 39192350, PMID 40194794, PMID 41807031, PMID 41965705, PMID 42386286, PMID 22491018, PMID 26275429, PMID 27803138, PMID 29463520, PMID 29949132, PMID 30219772, PMID 33059710, PMID 34041702, PMID 34618347, PMID 35305260, PMID 36715850, PMID 37308218, PMID 37925660, PMID 38488975, PMID 41448717, PMID 24429164, PMID 27889300
2015 (27), 2009 (22), 2016 (19), 2014 (15), 2008 (11), 2017 (8), 2018 (8), 2023 (6), 2005 (5), 2019 (5), 2004 (3), 1UG3AR077360-01 (1), D43TW009345 (1), K23AR050607 (1), P01AR043584 (1)